Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Ron, Mathijssen"'
Autor:
Lisanne Mout, Ronald de Wit, Debra Stuurman, Esther Verhoef, Ron Mathijssen, Corrina de Ridder, Martijn Lolkema, Wytske van Weerden
Publikováno v:
EBioMedicine, Vol 27, Iss C, Pp 182-186 (2018)
Inactivation of the androgen receptor (AR) pathway by androgen deprivation therapy (ADT) is the mainstay of (metastatic) prostate cancer therapy. Ultimately, the AR pathway will be re-activated despite castrate levels of circulating androgens. Thereb
Externí odkaz:
https://doaj.org/article/a53255eaf8ca4bd1acb6440f9ba6db90
Autor:
Sanne Buijs, Louwrens Braal, Stefan Buck, Noud F. van Maanen, Lonneke van der Meijden-Erkelens, Heleen Kuijper-Tissot van Patot, Esther Oomen-de Hoop, Lotte Saes, Sophia van den Boogerd, Liesbeth Struik, Quirine van Rossum-Schornagel, Ron Mathijssen, Stijn Koolen, Agnes Jager
Publikováno v:
Cancer Research. 83:P1-02
Background Tamoxifen is frequently used in the adjuvant treatment of hormone sensitive breast cancer. Unfortunately, tamoxifen can lead to bothersome side effects resulting in non-adherence in 40% of patients. Patients searching for relief from these
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c2c4b3952b8f5aebfbaa698482d8bbc2
https://doi.org/10.1158/1538-7445.sabcs22-p1-02-08
https://doi.org/10.1158/1538-7445.sabcs22-p1-02-08
Autor:
Wouter Ouwerkerk, Saskia Chielie, Marcel Bekkenk, Remco van Doorn, Christian Blank, John Haanen, Karlijn de Joode, Ron Mathijssen, Astrid van der Veldt, Ellen Kapiteijn, Karijn Suijkerbuijk, Kalijn Bol, Geke Hospers, Tomas Kirchhoff, Rosalie Luiten
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e57368202c96aca85f9206f4331405cc
https://doi.org/10.1136/jitc-2022-sitc2022.0088
https://doi.org/10.1136/jitc-2022-sitc2022.0088
Autor:
Leni van Doorn, Wesley J Visser, Daan C Van Dorst, Katrina M Mirabito Colafella, Stijn L Koolen, Anneke van Emond-de Mik, Ingrid Garrelds, Dominique Bovee, Esther Oomen-de Hoop, Sander Bins, Ferry A Eskens, Ewout Hoorn, Jan H Danser, Ron Mathijssen, Jorie Versmissen
Publikováno v:
Hypertension. 79
Vascular endothelial growth factor tyrosine kinase inhibitors (VEGFIs) are effective anti-cancer agents which often induce hypertension. VEGFI-induced hypertension was demonstrated to be sodium-sensitive in preclinical studies, but the sodium sensiti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9c401d72095282b0724be67d1eaae423
https://doi.org/10.1161/hyp.79.suppl_1.p068
https://doi.org/10.1161/hyp.79.suppl_1.p068
Autor:
Daan C Van Dorst, Sumeyye Kabadayi, Esther Oomen-de Hoop, Jan H Danser, Ron Mathijssen, Jorie Versmissen
Publikováno v:
Hypertension. 79
Vascular endothelial growth factor inhibitors (VEGFI) are highly effective anti-cancer agents, but frequently induce a rise in blood pressure (BP). The optimal treatment of this BP rise is currently unknown, and risk factors for this rise and its ass
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e3e193d990927ca6ee92fc8012deaac
https://doi.org/10.1161/hyp.79.suppl_1.p005
https://doi.org/10.1161/hyp.79.suppl_1.p005
Autor:
Clint Mizzi, Eleni Dalabira, Judit Kumuthini, Nduna Dzimiri, Istvan Balogh, Nazli Başak, Ruwen Böhm, Joseph Borg, Paola Borgiani, Nada Bozina, Henrike Bruckmueller, Beata Burzynska, Angel Carracedo, Ingolf Cascorbi, Constantinos Deltas, Vita Dolzan, Anthony Fenech, Godfrey Grech, Vytautas Kasiulevicius, Ľudevít Kádaši, Vaidutis Kučinskas, Elza Khusnutdinova, Yiannis L Loukas, Milan Macek, Halyna Makukh, Ron Mathijssen, Konstantinos Mitropoulos, Christina Mitropoulou, Giuseppe Novelli, Ioanna Papantoni, Sonja Pavlovic, Giuseppe Saglio, Jadranka Sertić, Maja Stojiljkovic, Andrew P Stubbs, Alessio Squassina, Maria Torres, Marek Turnovec, Ron H van Schaik, Konstantinos Voskarides, Salma M Wakil, Anneke Werk, Maria Del Zompo, Branka Zukic, Theodora Katsila, Ming Ta Michael Lee, Alison Motsinger-Rief, Howard L Mc Leod, Peter J van der Spek, George P Patrinos
Publikováno v:
PLoS ONE, Vol 12, Iss 2, p e0172595 (2017)
[This corrects the article DOI: 10.1371/journal.pone.0162866.].
Externí odkaz:
https://doaj.org/article/bfb926067d6344b3b90c530f5e7e1bb4
Autor:
Clint Mizzi, Eleni Dalabira, Judit Kumuthini, Nduna Dzimiri, Istvan Balogh, Nazli Başak, Ruwen Böhm, Joseph Borg, Paola Borgiani, Nada Bozina, Henrike Bruckmueller, Beata Burzynska, Angel Carracedo, Ingolf Cascorbi, Constantinos Deltas, Vita Dolzan, Anthony Fenech, Godfrey Grech, Vytautas Kasiulevicius, Ľudevít Kádaši, Vaidutis Kučinskas, Elza Khusnutdinova, Yiannis L Loukas, Milan Macek, Halyna Makukh, Ron Mathijssen, Konstantinos Mitropoulos, Christina Mitropoulou, Giuseppe Novelli, Ioanna Papantoni, Sonja Pavlovic, Giuseppe Saglio, Jadranka Setric, Maja Stojiljkovic, Andrew P Stubbs, Alessio Squassina, Maria Torres, Marek Turnovec, Ron H van Schaik, Konstantinos Voskarides, Salma M Wakil, Anneke Werk, Maria Del Zompo, Branka Zukic, Theodora Katsila, Ming Ta Michael Lee, Alison Motsinger-Rief, Howard L Mc Leod, Peter J van der Spek, George P Patrinos
Publikováno v:
PLoS ONE, Vol 11, Iss 9, p e0162866 (2016)
Pharmacogenomics aims to correlate inter-individual differences of drug efficacy and/or toxicity with the underlying genetic composition, particularly in genes encoding for protein factors and enzymes involved in drug metabolism and transport. In sev
Externí odkaz:
https://doaj.org/article/65d317caa72545be89067d0f39dc3afe
Autor:
J.P. Van Kooten, Michelle Dietz, Niels Guchelaar, Alexandra Brandt-Kerkhof, Stijn Koolen, Burger Jacobus, Ron Mathijssen, Cornelis Verhoef, Joachim Aerts, Eva Madsen
Publikováno v:
European Journal of Surgical Oncology. 49:e201
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d362e001c2c60a662ea72df07d9de9c1
https://doi.org/10.1016/j.ejso.2022.11.552
https://doi.org/10.1016/j.ejso.2022.11.552
Autor:
C. Louwrens Braal, Justin D. Westenberg, Sanne M. Buijs, Steven Abrams, Tessa Mulder, Ron van Schaik, Stijn Koolen, Agnes Jager, Ron Mathijssen
Introduction: Endoxifen – the principal metabolite of tamoxifen – is subject to a high inter-individual variability in serum concentration. Numerous attempts have been made to explain this, but thus far only with limited success. By applying pred
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b183864462e0ca251b3b5fc12f0f6fb
https://doi.org/10.21203/rs.3.rs-689481/v1
https://doi.org/10.21203/rs.3.rs-689481/v1
Autor:
Daan Van Dorst, Katrina Mirabito Colafella, Leni Van Doorn, Richard Van Veghel, Ingrid Garrelds, Ron Mathijssen, Jan Danser, Jorie Versmissen
Publikováno v:
Journal of Hypertension, 40(Suppl. 1). Lippincott Williams & Wilkins
OBJECTIVE: Angiogenesis inhibitors are effective anti-cancer agents, but also cause hypertension and renal injury. Earlier, we observed in rats that high-dose aspirin (capable of blocking cyclooxygenase (COX)-1 and -2) prevented these side effects be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1a7a38894d59da195c1639eaa392eb1
https://pure.eur.nl/en/publications/e2f3b44a-25d2-4c98-b342-227dc0e07e03
https://pure.eur.nl/en/publications/e2f3b44a-25d2-4c98-b342-227dc0e07e03